|
Isolated Protein Domain Linked to Tumors Friday, February 20, 2009 - Anuradha Menon Home >> Headlines >> Cancer Research   
|
|
When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix metalloproteinases (MMPs). Now, researchers at Rensselaer Polytechnic Institute have shown that creating drugs that inactivate a different part of the MMP enzyme could have the capacity to target the tumor without the damaging side effects. (source: news.rpi.edu)
|
|
|
|
|
|
|
|
| Related News |
|
Slowing Cancer Metabolism |
|
Interferon Based Drug May Eliminate Breast Cancer |
| Related Pictures |
|
Purple Tomatoes to Fight Cancer |
|
New Contrast Agent to Help Fight Cancer |
| Other Articles |
|
The Future of Electronic Paper |
|
2008 In Technology |
